| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cb79011635aece4870341b7bdd0469 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf1a7c3c2a195d130b037bbf70ecc506 |
| publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2012203061-A1 |
| titleOfInvention |
Compounds, composition, methods, targets for cancer therapy |
| abstract |
This invention describes methods and pharmaceutical compositions for combinational cancer treatments that are capable of blocking cancer cell trans-plasma membrane electron transfer and respiration in combination with inhibiting cancer cell hypoxia responses to induce cell death. It also 5 identified genes as target for anti-cancer drug development and enhancement of the chemotherapeutic drug effect for the treatment of cancer. This invention points to a novel method and principle for a new avenue of developing more efficient and low or non-cytotoxic cancer treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113633625-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113633625-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112438977-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112438977-A |
| priorityDate |
2007-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |